Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides caloric support and helps correct hypoglycemia. Sodium chloride is an electrolyte that maintains osmotic balance and fluid volume.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; dosage depends on fluid and electrolyte requirements. Typical maintenance: 75-150 mL/kg/day for adults, administered as continuous infusion.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateNot applicable for dextrose as it is rapidly metabolized; plasma glucose half-life is approximately 1.7-2.0 hours after IV infusion but highly variable depending on metabolic demand and insulin activity. For sodium chloride, ions are continuously regulated by renal handling; no traditional half-life.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is metabolized to CO2 and water via glycolysis and the Krebs cycle; negligible renal excretion (<5%). Sodium chloride is excreted renally with sodium and chloride ions freely filtered and variably reabsorbed (99% reabsorption under normal conditions, but excretion increases with excess intake).
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."